XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Stock Option Plans (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options

Stock option activity for employees and non-employees under the Equity Compensation Plans for the six months ended June 30, 2022 was as follows:

 

 

Options

 

 

Weighted
Average
Exercise Price

 

 

Weighted Average Remaining Contractual Life (years)

 

 

Aggregate Intrinsic Value

 

Outstanding options, December 31, 2021

 

 

5,107,672

 

 

$

2.44

 

 

 

5.78

 

 

$

28,948,535

 

Granted

 

 

528,711

 

 

$

2.84

 

 

 

 

 

 

 

Forfeited

 

 

(256,475

)

 

$

4.81

 

 

 

 

 

 

 

Exercised

 

 

(90,264

)

 

$

0.85

 

 

 

 

 

 

 

Outstanding options, June 30, 2022

 

 

5,289,644

 

 

$

2.64

 

 

 

4.88

 

 

$

2,146,863

 

Options vested and exercisable, June 30, 2022

 

 

3,950,063

 

 

$

1.34

 

 

 

3.69

 

 

$

2,146,863

 

Summary of Assumptions Used to Calculate Estimated Fair Value of Stock Options

The estimated fair value of stock options granted to employees and consultants during the three and six months ended June 30, 2022 and 2021, were calculated using the Black-Scholes option-pricing model using the following assumptions:

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2022

 

2021

 

2022

 

2021

Expected volatility

 

85.4

 

%

 

75.9 - 104.3

 

%

 

78.0 - 85.4

 

%

 

75.9 - 104.3

 

%

Weighted-average volatility

 

 

85.4

 

%

 

 

96.7

 

%

 

 

79.0

 

%

 

 

98.1

 

%

Expected dividends

 

 

%

 

 

%

 

 

%

 

 

%

Expected term (in years)

 

5.89

 

 

 

6.25

 

 

 

5.50 - 6.08

 

 

 

6.25

 

 

Risk-free rate

 

3.03

 

%

 

0.14 - 0.59

 

%

 

1.38 - 3.03

 

%

 

0.14 - 0.59

 

%

Summary of Restricted Stock

Stock award activity for employees and non-employees under the Equity Compensation Plans for the six months ended June 30, 2022 was as follows:

 

 

Number of shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Unvested as of December 31, 2021

 

 

 

 

$

 

Granted

 

 

300,000

 

 

$

1.89

 

Vested

 

 

 

 

$

 

Forfeited

 

 

 

 

$

 

Unvested as of June 30, 2022

 

 

300,000

 

 

$

1.89

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense for the three and six months ended June 30, 2022 and 2021 was as follows:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Research and development

 

$

149,814

 

 

$

303,461

 

 

$

518,039

 

 

$

514,404

 

General and administrative

 

 

420,047

 

 

 

129,970

 

 

 

949,422

 

 

 

268,142

 

Total

 

$

569,861

 

 

$

433,431

 

 

$

1,467,461

 

 

$

782,546